PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland, UK. Electronic address: Frederick.Ho@glasgow.ac.uk.\', \'School of Pharmacy, University College London, London, England, UK; Centre for Safe Medication Practice and Research, Department of Pharmacy and Pharmacology, University of Hong Kong, Hong Kong, China.\', \'Department of Medicine, School of Clinical Medicine, University of Cambridge, England, UK.\', \'NHS Greater Glasgow and Clyde, Glasgow, Scotland, UK.\', \'Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, Scotland, UK.\', \'Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0025-6196(21)00511-510.1016/j.mayocp.2021.07.002
?:hasPublicationType
?:journal
  • Mayo Clinic proceedings
is ?:pmid of
?:pmid
?:pmid
  • 34607634
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.551
?:rankingScore_hIndex
  • 153
is ?:relation_isRelatedTo_publication of
?:title
  • Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients: A Self-Controlled Case Series Analysis of a Nationwide Cohort.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all